202 1, zhifei biology is favored by capital. In the third quarter, overseas investors increased their positions by 3.36 million shares, with a market value of 9 billion yuan at the end of the third quarter.
Anhui Zhifeilong Kyle Biopharmaceutical Co., Ltd. (hereinafter referred to as "Zhifeilong Kyle") is a high-tech enterprise integrating research and development, production and sales of biological products.